Diabetes as a Risk Factor for Herpes Zoster Infection: Results of a Population-Based Study in Israel

Anthony Heymann1, Gabriel Chodick1, Thomas Karpati1, Lilach Kamer1, Eyal Kremer1, Manfred S. Green2, Ehud Kokia1, Varda Shalev1
1Medical Division, Maccabi Healthcare Services, 27 HaMered St, Tel Aviv, 68125, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aebi C, Fischer K, Gorgievski M, Matter L and Muhlemann K (2001). Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine 19: 3097–3103

Gnann J and Whitley R (2002). Herpes zoster. N Engl J Med 347: 340–346

Geerlings S and Hoepelman A (1999). Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26: 259–265

Diabetes Control and Complications Trial Research Group (1995). The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122: 561–568

Ragozzino M, Melton L, Kurland L, Chu C and Perry H (1982). Population based study of herpes zoster and its sequelae. Medicine 61: 310–316

Brown G (1976). Herpes zoster: correlation of age, sex, distribution, neuralgia and associated disorders. South Med J 69: 576–578

Porter B (2004). The development of primary care in Israel. Isr Med Assoc J 6: 723–727

Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007; 23: 3–13

Calvet H and Yoshikawa T (2001). Infections in diabetes. Infect Dis Clin North Am 15: 407–421

Brown G (1976). Herpes zoster: correlation of age, sex, distribution, neuralgia and associated disorders. South Med J 69: 576–578

Kaiserman I, Kaiserman N, Nakar S and Vinker S (2005). Herpetic eye disease in diabetic patients. Ophthalmology 112: 2184–2188

Kalman C and Laskin O (1986). Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med 81: 775–778

Gnann J Jr and Whitley R (2002). Clinical practice: herpes zoster. N Engl J Med 347: 340–346

Helgason S, Sigurdsson J and Gudmundsson S (1996). The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Pract 2: 12–16

Rubben A, Baron J and Grussendorf-Conen E (1997). Routine detection of herpes simplex virus and varicella zoster virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex. Br J Dermatol 137: 259–261

Thomas S and Hall A (2004). What does epidemiology tells us about risk factors for herpes zoster?. Lancet Infect Dis 4: 26–33

McCormick A, Fleming D, Charlton J. (HM Stationery Office): Morbidity statistics from general practice: 4th national study 1991–92. A study carried out by the Royal College of General Practitioners, the Office of Population Censuses and Surveys, and the Department of Health 1995

de Melker H, Berbers G and Hahne S, et al. (2006). The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 24: 3946–3952

Opstelten W, Schellevis F, Verheij T, Moons K and Essen G (2006). Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 16: 692–695

Arndt V, Vine MF and Weigle K (1999). Environmental chemical exposures, risk of herpes zoster. Environ Health Perspect 107: 835–841

Moszczynski P, Zabinski Z, Moszczynski P Jr, Rutowski J, Slowinski S Jr and Tabarowski Z (2001). Immunological findings in cigarette smokers . Toxicol Lett 118: 121–127

Cook RT (1998). Alcohol abuse, alcoholism and damage to the immune system: a review. Alcohol Clin Exp Res 22: 1927–1942

Mitka M (2006). FDA approves shingles vaccine herpes zoster vaccine targets older adults. JAMA 296: 157–158